Private equity firm Longreach Group, which specializes in the Asian market, is in the process of auctioning off its medical equipment unit, Quasar Medical. According to Reuters, bidders include Boyu Capital, Hillhouse Capital, and BPEA EQT. Quasar Medical is valued at USD 600 million and reported sales of USD 30 million in 2022. The due diligence process is underway, with final bids expected to be submitted before the end of June.
Quasar Medical’s Impressive Track Record and Clientele
Quasar Medical, known for its high-quality medical devices such as heart sensors, respiratory catheters, and beauty equipment, boasts a prestigious clientele that includes Johnson & Johnson, Medtronic, and Unilever, among other global top 500 brands. The company was acquired by Longreach Group in April 2019, marking a strategic expansion into the medical equipment sector.
Quasar Medical’s Origins and Growth
Founded in Hong Kong in 1988 by Boaz Amitai from Israel, Quasar Medical has grown to become a leading player in the medical equipment industry. Its reputation for innovation and quality has made it a sought-after asset, attracting significant interest from major players in the private equity market.-Fineline Info & Tech
